BOOK RELEASE. Anja Smits, professor of neurology at the University of Gothenburg, has debuted as a fiction writer. Though both science and the hospital environment are important parts of the story, the book is not about her. It is called Den tysta korridoren (“The Silent Corridor”) and was published by Ekström & Garay on April 28. If you are employed by Sahlgrenska Academy or affiliated with it, you can win…
OligoNova Network gathers research on drugs of the future
INTERACTION. Yet another important step for the development of Life Science in the Gothenburg region was taken recently, when leading oligonucleotide experts gathered for a first physical meeting. The network conference took place on April 25-26 at GoCo Health innovation City in Mölndal. The conference was organized by OligoNova, Sweden’s national infrastructure for oligonucleotide therapies and part of the SciLifeLab Drug Discovery and Development platform (DDD). The Director of Science…
Towards improved diagnostics for several types of dementia
GRANT. Twenty years of research have culminated in blood tests that can be used for clinical diagnosis of Alzheimer’s disease. Henrik Zetterberg, professor of neurochemistry, has just been awarded the European Research Council’s prestigious Advanced Grant to establish similar markers for other forms of dementia. Long-term research into clinical neurochemistry at the University of Gothenburg has resulted in three well-established cerebrospinal fluid markers that are used around the world to…
OligoNova HUB – Innovative Development of a New Class of Drugs
INFRASTRUCTURE. OligoNova Hub is Sweden’s new national infrastructure for drug development, specifically focused on therapeutic oligonucleotides. Here, researchers with expertise in e.g. bioinformatics, chemistry and cellular biology will work with innovative development projects of drugs for patient groups that currently lack appropriate treatment. Pär Matsson, professor of pharmacokinetics at the Department of Pharmacology, Sahlgrenska Academy, is head of the OligoNova Hub. “My research focuses on drug development, especially how to…
Anders Rosengren receives Swedish Heart Lung Foundation’s Prevention Grant
GRANTS. This year’s recipient of the Swedish Heart Lung Foundation’s prevention grant of SEK 3 million is Anders Rosengren, a professor at the University of Gothenburg. He heads a project to investigate how a digital tool might help prevent cardiovascular disease. “Anders Rosengren’s study may open up a new way of preventing cardiovascular disease. The tool can easily be used by many people free of charge to encourage healthy living…